BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6115041)

  • 1. Selective inhibition of [3H]lysergic acid diethylamide binding to mouse brain membranes by ethanol.
    Hirsch JD
    J Pharm Pharmacol; 1981 Jul; 33(7):475-7. PubMed ID: 6115041
    [No Abstract]   [Full Text] [Related]  

  • 2. High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding.
    Fillion GM; Rousselle JC; Fillion MP; Beaudoin DM; Goiny MR; Deniau JM; Jacob JJ
    Mol Pharmacol; 1978 Jan; 14(1):50-9. PubMed ID: 625289
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.
    Bennett JP; Snyder SH
    Mol Pharmacol; 1976 May; 12(3):373-89. PubMed ID: 6896
    [No Abstract]   [Full Text] [Related]  

  • 5. [High affinity binding of 5-hydroxytryptamine to some membrane preparations from cattle brain. Relationship to lysergic acid diethylamide (LSD)].
    Fillion G; Fillion MP; Rousselle JC; Beaudoin D; Goiny M; Jacob J
    C R Acad Hebd Seances Acad Sci D; 1977 Mar; 284(11):979-81. PubMed ID: 405135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific receptor sites for d-lysergic acid diethylamide in rat brain: effects of neurotransmitters, amine antagonists, and other psychotropic drugs.
    Lovell RA; Freedman DX
    Mol Pharmacol; 1976 Jul; 12(4):620-30. PubMed ID: 8700
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological characterization of 3H-LSD binding sites in mouse brain in vivo.
    Duchemin AM; Quach TT; Rose C; Schwartz JC
    Life Sci; 1979 Jan; 24(5):401-9. PubMed ID: 431327
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics of D-lysergic acid diethylamide binding to subcellular fractions derived from rat brain.
    Farrow JT; Van Vunakis H
    Biochem Pharmacol; 1973 May; 22(9):1103-13. PubMed ID: 4695669
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of [3H]LSD with serotonin receptors in human brain.
    Cross AJ
    Eur J Pharmacol; 1982 Aug; 82(1-2):77-80. PubMed ID: 7128680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serotonin and D-lysergic acid diethylamide receptors in the mammalian brain].
    Vlasova TI; Kirzon MV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (5):5-16. PubMed ID: 6264979
    [No Abstract]   [Full Text] [Related]  

  • 12. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent.
    Christian ST; Harrison R; Quayle E; Pagel J; Monti J
    Biochem Med; 1977 Oct; 18(2):164-83. PubMed ID: 20877
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.
    Bennett JP; snyder SH
    Brain Res; 1975 Sep; 94(3):523-44. PubMed ID: 239784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT and LSD high affinity binding sites to brain synaptosomal membranes [proceedings].
    Fillion G; Fillion MP; Jacob J; Rousselle JC
    Br J Pharmacol; 1976 Nov; 58(3):425P-426P. PubMed ID: 990612
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo 3H-d-LSD binding in small punched out rat brain regions.
    Kräuchi K; Feer H
    Experientia; 1980 Sep; 36(9):1094-5. PubMed ID: 7418848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.
    Burt DR; Creese I; Snyder SH
    Mol Pharmacol; 1976 Jul; 12(4):631-8. PubMed ID: 958211
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in d-[3H]lysergic acid diethylamide binding in mouse cortex and hippocampus in vivo and in vitro revealed by radioautography and rapid filtration studies.
    Ebersole BJ; Weinstein H; Maayani S
    J Pharmacol Exp Ther; 1984 Jun; 229(3):865-71. PubMed ID: 6726661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The subcellular distribution of lysergic acid diethylamide in the rat brain.
    Faragalla FF
    Experientia; 1972 Dec; 28(12):1426-7. PubMed ID: 4654194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.